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ApoptosisSepsis is characterized by systematic inﬂammation and contributes to cardiac dysfunction. This study was
designed to examine the effect of protein kinase B (Akt) activation on lipopolysaccharide-induced cardiac
anomalies and underlying mechanism(s) involved. Mechanical and intracellular Ca2+ properties were exam-
ined in myocardium from wild-type and transgenic mice with cardiac-speciﬁc chronic Akt overexpression
following LPS (4 mg/kg, i.p.) challenge. Akt signaling cascade (Akt, phosphatase and tensin homologue delet-
ed on chromosome ten, glycogen synthase kinase 3 beta), stress signal (extracellular-signal-regulated ki-
nases, c-Jun N-terminal kinases, p38), apoptotic markers (Bcl-2 associated X protein, caspase-3/-9),
endoplasmic reticulum (ER) stress markers (glucose-regulated protein 78, growth arrest and DNA damage
induced gene-153, eukaryotic initiation factor 2α), inﬂammatory markers (tumor necrosis factor α,
interleukin-1β, interleukin-6) and autophagic markers (Beclin-1, light chain 3B, autophagy-related gene 7
and sequestosome 1) were evaluated. Our results revealed that LPS inducedmarked decrease in ejection frac-
tion, fractional shortening, cardiomyocyte contractile capacity with dampened intracellular Ca2+ release and
clearance, elevated reactive oxygen species (ROS) generation and decreased glutathione and glutathione disul-
ﬁde (GSH/GSSG) ratio, increased ERK, JNK, p38, GRP78, Gadd153, eIF2α, BAX, caspase-3 and -9, downregulated
B cell lymphoma 2 (Bcl-2), the effects of whichwere signiﬁcantly attenuated or obliterated by Akt activation. Akt
activation itself did not affect cardiac contractile and intracellular Ca2+ properties, ROS production, oxidative
stress, apoptosis and ER stress. In addition, LPS upregulated levels of Beclin-1, LC3B and Atg7, while suppressing
p62 accumulation. Akt activation did not affect Beclin-1, LC3B, Atg7 and p62 in the presence or absence of LPS.
Akt overexpression promoted phosphorylation of Akt and GSK3β. In vitro study using the GSK3β inhibitor
SB216763 mimicked the response elicited by chronic Akt activation. Taken together, these data showed that
Akt activation ameliorated LPS-induced cardiac contractile and intracellular Ca2+ anomalies through inhibition
of apoptosis and ER stress, possibly involving an Akt/GSK3β-dependent mechanism.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Sepsis is a devastating medical problem, representing a main
cause of high mortality in critically ill patients [1–3]. The most severe
sequelae for patients with sepsis are considered to be septic shock,
leading to multiple organ and system failure. Cardiovascular in partic-
ular cardiac anomalies develop in nearly 40% of patients with sepsis,
accounting for ~15% of mortality as a result of sepsis [4]. Patients
with septic shock display ventricular dilation, decreased myocardiallege ofHealth Sciences, Laramie,
2953.
n@uwyo.edu (J. Ren).
l rights reserved.ejection fraction and contractility [5,6]. It is well known that lipopoly-
saccharide (LPS) from the gram-negative bacteria triggers sepsis en
route to systemic organ failure including compromised cardiovascular
function [7]. A number of mechanisms have been put forwards in the
etiology of cardiovascular complications in sepsis including oxidative
stress, inducible nitric oxide synthase (iNOS), activation of stress signals
including mitogen-activated protein kinase (MAPK), and the stress-
activated protein kinase/Jun-amino-terminal kinase (SAPK/JNK) [8–11].
Nonetheless, the precise nature behind initiation and progression of
cardiac anomalies in sepsis remains elusive, thus making effective thera-
peutic remedy rather challenging [3].
The phosphoinositide 3 kinase and protein kinase B (PI3K/Akt)
signaling pathway plays an essential role in the regulation of cell pro-
liferation, survival and inﬂammatory processes [12]. Earlier ﬁndings
from our group revealed that cardiac-speciﬁc overexpression of active
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cardiac contractile dysfunction via an Akt-glycogen synthase kinase
3β (GSK3β)-mediated mechanism [13,14]. Inhibition of GSK3β has
also been demonstrated to suppress the proinﬂammatory response
and lessen organ injury in endotoxemia as well as to mediate protec-
tion against endotoxin shock [15,16]. Along the same line, insulin
therapy is found beneﬁcial for LPS-induced multiple organ injury
through a GSK3β-mediated mechanism independently of any effects on
blood glucose levels [17,18]. Furthermore, Kapoor and colleagues also
revealed a role for Akt-GSK3β in peroxisome proliferator-activated
receptor-β/δ-offered protection against endotoxemia-induced injury
[19]. Despite accumulating evidence for an essential role of GSK3β in
endotoxemia [15–20], the precise role of Akt in septic shock-induced
myocardial anomalies remains elusive. To this end, our present study
was designed to test the hypothesis that the Akt-GSK3β signaling plays
an essential role in endotoxin LPS-elicited cardiac dysfunction. Mechani-
cal and intracellular Ca2+ properties were examined in hearts from
wild-type (WT) and cardiac-speciﬁc overexpression of the active mutant
of Akt (Akt overexpression, AOE) mice following LPS challenge. Akt sig-
naling (Akt, PTEN and GSK3β), oxidative stress signaling (ERK, JNK and
p38), apoptotic protein markers (Bax, caspase-3/-9), endoplasmic reticu-
lum (ER) stress markers (GRP78, Gadd153 and eIF2α), proinﬂammatory
markers (TNFα, IL-1β and IL-6) and the autophagic markers (Beclin-1,
LC3B, Atg7, and p62) were evaluated.WT
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B2. Materials and methods
2.1. Experimental animals and LPS treatment
All animal procedures were approved by the Institutional Animal
Use and Care Committee at the University of Wyoming (Laramie,
WY). Mice overexpressing the hemagglutinin-tagged Akt (MyAkt)
with src myristoylation signal under the direction of the murine
α-myosin heavy chain (MHC) promoter were kindly provided by
Dr. Anthony Rosenzweig (Harvard Medical School, Boston, MA). The
cDNA encoding My-Akt was subcloned downstream of the 5.5-kb
murine α-MHC promoter and was used to generate cardiac-speciﬁc
Akt transgenic mice through oocyte injection. My-Akt transgenic
mice were genotyped by PCR. Adult (8–12 week-old) Akt transgenic
and wild-type (WT) mice were used. Mice were maintained on a
12:12-h light–dark illumination cycle and were allowed food and
water ad libitum. On the day of experimentation, both AOE and WT
mice were injected intraperitoneally with 4 mg/kg Escherichia coli
O55:B5 LPS dissolved in sterile saline or an equivalent volume ofTable 1
General characteristics of WT and AOE mice treated with or without LPS (4 mg/kg, i.p.,
6 h).
WT WT-LPS AOE AOE-LPS
Body weight (g) 24.5 ± 0.7 24.4 ± 0.4 24.2 ± 1.8 23.5 ± 0.7
Heart weight (mg) 114 ± 4 114 ± 4 121 ± 26 118 ± 8
Heart/body weight (mg/g) 5.64 ± 0.21 5.31 ± 0.18 5.49 ± 0.31 5.41 ± 0.25
Liver weight (g) 0.95 ± 0.15 0.98 ± 0.07 0.97 ± 0.04 1.01 ± 0.09
Kidney weight (g) 0.29 ± 0.03 0.29 ± 0.01 0.27 ± 0.01 0.28 ± 0.01
Heart rate (bpm) 489 ± 27 466 ± 36 460 ± 40 470 ± 22
Wall thickness (mm) 0.92 ± 0.02 0.87 ± 0.05 0.95 ± 0.09 0.88 ± 0.06
LVEDD (mm) 2.29 ± 0.17 2.33 ± 0.14 2.39 ± 0.14 2.26 ± 0.09
LVESD (mm) 1.09 ± 0.08 1.39 ± 0.13a 1.17 ± 0.06 0.93 ± 0.07
Normalized LV mass
(mg/g)
2.41 ± 0.20 2.45 ± 0.27 2.55 ± 0.48 2.39 ± 0.24
Fractional shortening (%) 52.4 ± 1.9 36.2 ± 3.5a 50.7 ± 2.2 52.5 ± 2.8b
Ejection fraction (%) 88.9 ± 1.4 72.8 ± 4.3a 90.2 ± 1.8 88.2 ± 2.6b
LV: left ventricular; EDD: end diastolic diameter; ESD: end systolic diameter; mean ± SEM,
n = 6–7 mice per group.
a p b 0.05 vs. WT group.
b p b 0.05 vs. WT-LPS group.pathogen-free saline for control. Six hours following LPS injection,
mice were sacriﬁced for experimentation [21,22].
2.2. Echocardiographic assessment
Cardiac geometry and function were evaluated in anesthetized
(ketamine 80 mg/kg and xylazine 12 mg/kg, i.p.) mice using the
2-D guided M-mode echocardiography (Sonos 5500, Phillips Medical
System, Andover, MA) equipped with a 15–16 MHz linear transducer.
Left ventricular (LV) anterior and posterior wall dimensions during
diastole and systole were recorded from 3 cycles using M-mode
echocardiography using methods adopted by the American Society
of Echocardiography. Fractional shortening was calculated from LV
end-diastolic (LVEDD) and LV end-systolic (LVESD) diameters using
the equation (LVEDD − LVESD) / LVEDD. Echocardiographic LV
mass was calculated using the equation of [(LVEDD + septal wall
thickness + posterior wall thickness)3 − LVEDD3] × 1.055, where
1.055 mg/mm3 is the density of myocardium. Ejection fraction wasWT
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Fig. 1. Effect of Akt overexpression (AOE) on LPS-induced changes inwhole heart function
using the Langendorff perfusion system. WT and AOE mice received LPS (4 mg/kg, i.p.,
6 h) prior to assessment of heart function. A: Left ventricular developed pressure
(LVDP); B: +dP/dt; and C: −dP/dt. Mean ± SEM, n = 5–6 mice per group, *p b 0.05
vs.WT group, #p b 0.05 vs.WT-LPS group.
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Fig. 2. Effect of Akt overexpression (AOE) on LPS-induced changes in cardiomyocyte contractile properties. WT and AOE mice received LPS (4 mg/kg, i.p., 6 h) prior to assessment of
mechanical function. A: Resting cell length; B: peak shortening (% of resting cell length); C: maximal velocity of shortening (+dL/dt); D: maximal velocity of relengthening (−dL/dt);
E: time-to-peak shortening (TPS); and F: time-to-90% relengthening (TR90). Mean ± SEM, n = 90–100 cells from 3mice per group, *p b 0.05 vs.WT group, #p b 0.05 vs.WT-LPS group.
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equation of (LVEDD3 − LVESD3)/LVEDD3 × 100. Heart rates were
averaged over 10 cycles [23].
2.3. Langendorff-perfused heart function
Langendorff-perfused heart function was assessed using the
ADInstruments PowerLab system. In brief, mice were anesthetized
(ketamine 80 mg/kg and xylazine 12 mg/kg, i.p.) and hearts were per-
fused with KHB containing 7 mM glucose, 0.4 mM oleate, 1% bovine
serum albumin and a low level of insulin (10 μU/ml). The perfusion
was initiated in the retrograde mode through the cannulated aorta.
Hearts were perfused at a constant aortic pressure of 4 mm Hg at base-
line for 60 min. A ﬂuid-ﬁlled latex balloon connected to a solid-state
pressure transducer was inserted into the left ventricle to measure the
pressure. Left ventricular developed pressure (LVDP), the ﬁrst deriva-
tive of LVDP, namely, themaximum rate of left ventricular pressure de-
velopment (+dP/dt) and themaximum rate of left ventricular pressure
decline (−dP/dt) were recorded using a digital acquisition system at aballoon volume which resulted in a baseline LV end-diastolic pressure
of 5 mm Hg [24].
2.4. Isolation of murine cardiomyocytes and in vitro drug treatment
Cardiomyocytes were isolated as described [25]. In brief, mice were
anesthetized using ketamine and xylazine (ketamine 80 mg/kg and
xylazine 12 mg/kg, i.p.). Hearts were rapidly removed and perfused
with oxygenated (5% CO2/95% O2) Krebs–Henseleit bicarbonate (KHB)
buffer containing (in mM) 118 NaCl, 4.7 KCl, 1.25 CaCl2, 1.2 MgSO4,
1.2 KH2PO4, 25 NaHCO3, 10 HEPES and 11.1 glucose. Hearts were then
perfused with a Ca2+-free KHB containing liberase blendzyme 4
(Hoffmann-La Roche Inc., Indianapolis, IN) for 20 min. After perfusion,
left ventricles were removed and minced to disperse cardiomyocytes in
a Ca2+-free KHB buffer. Extracellular Ca2+ was added incrementally
back to 1.2 mM. Myocyte yield was ~70% which was unaffected by LPS
orAkt activation.Only rod-shapedmyocyteswith clear edgeswere select-
ed for mechanical and intracellular Ca2+ studies. Cells were used within
6 h of isolation. To directly assess the role of oxidative stress, ER stress
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Fig. 3. Effect of Akt overexpression (AOE) on LPS-induced changes in intracellular Ca2+ handling measured using Fura-2. WT and AOE mice received LPS (4 mg/kg, i.p., 6 h) prior to
assessment of intracellular Ca2+ properties in cardiomyocytes. A: Baseline Fura-2 ﬂuorescence intensity (FFI); B: change in FFI (ΔFFI) in response to electrical stimuli; C: single ex-
ponential intracellular Ca2+ decay rate; and D: bi-exponential intracellular Ca2+ decay rate. Mean ± SEM, n = 80–90 cells from 3 mice per group, *p b 0.05 vs. WT group,
#p b 0.05 vs. WT-LPS group.
851M. Dong et al. / Biochimica et Biophysica Acta 1832 (2013) 848–863and stress signaling in LPS-induced cardiomyocyte dysfunction, murine
cardiomyocytes were incubated with or without LPS (4 μg/ml) and/or
the GSK3β inhibitor SB216763 (10 μM) at 37 °C for 2 h [14,26].
2.5. Cell shortening/relengthening
Mechanical properties of cardiomyocytes were assessed using a
SoftEdge MyoCam system (IonOptix Corporation, Milton, MA). In
brief, cardiomyocytes were placed in a chamber mounted on the stage
of an inverted microscope (Olympus, IX-70) and superfused at 25 °C
with a buffer containing (in mM): 131 NaCl, 4 KCl, 1 CaCl2, 1 MgCl2,
10 glucose and 10 HEPES, at pH 7.4. The cells were ﬁeld stimulated
with suprathreshold voltage at a frequency of 0.5 Hz, 3 ms duration,
using a pair of platinumwires placed on opposite sides of the chamber
and connected to an electrical stimulator (FHC Inc., Brunswick, NE). The
myocyte being studied was displayed on a computer monitor using an
IonOptix MyoCam camera. An IonOptix software was used to capture
changes in cell length during shortening and relengthening. Cell shorten-
ing and relengthening were assessed using the following indices: peak
shortening (PS), maximal velocities of cell shortening and relengthening
(±dL/dt), time-to-PS (TPS), and time-to-90% relengthening (TR90) [21].
2.6. Intracellular Ca2+ transient
Cardiomyocytes were loaded with Fura-2/AM (0.5 μM) for 10 min
and ﬂuorescence measurements were recorded with dual-excitation
ﬂuorescence photomultiplier system (IonOptix). Cardiomyocytes were
placed on an Olympus IX-70 inverted microscope and imaged through
a Fluor 40× oil objective. Cells were exposed to light emitted by a
75-W lamp and passed through either 360 nm or a 380 nm ﬁlter,while being stimulated to contract at 0.5 Hz. Fluorescence emissions
were detected between 480 nm and 520 nm by a photomultiplier
tube after ﬁrst illuminating the cells at a 360 nm 0.5 s, then at 380 nm
for the duration of the recording protocol (333 Hz sampling rate). The
360 nm excitation scan can be repeated at the end of the protocol and
qualitative changes in intracellular Ca2+ concentration were inferred
from the ratio of Fura-2 ﬂuorescence intensity at two wavelengths
(360/380). Fluorescence decay timewas assessed as an indication of in-
tracellular Ca2+ clearing. Single exponential curveﬁtwas applied to cal-
culate the intracellular decay Ca2+ constant [27].
2.7. Generation of intracellular reactive oxygen species (ROS)
Production of ROS was evaluated by changes in the ﬂuorescence in-
tensity resulted from oxidation of the intracellular ﬂuoroprobe 5-(and
-6)-chloromethyl-2′,7′-dichlorodihydroﬂuorescein diacetate (CM-H2-
DCF-DA,Molecular Probes, Eugene, OR). In brief, cardiomyocyteswere in-
cubated with 25 μM CM-H2DCF-DA for 30 min at 37 °C. The cells were
then rinsed and the ﬂuorescence intensity wasmeasured using a ﬂuores-
cent micro-plate reader at the excitation and emission wavelengths of
480 nm and 530 nm respectively (Molecular Devices, Sunnyvale, CA).
Untreated cells without ﬂuorescence were used to determine the back-
ground ﬂuorescence. The ﬁnal results were expressed as the ratio of the
ﬂuorescent intensity to respective protein content [27].
2.8. Glutathione and glutathione disulﬁde (GSH/GSSG) assay
The ratio of GSH/GSSG was used as an indicator of oxidative stress.
Myocardial tissues from WT and AOE mice treated with or without
LPS were homogenized in 4 volumes (w/v) of 1% picric acid. Acid
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Fig. 4. ROS production, oxidative stress as well as changes in phosphorylation of Akt (Ser473 or Thr308), GSK3β, and PTEN in cardiomyocytes from WT and AOE mice treated with or
without LPS (4 mg/kg, i.p., 6 h). A: ROS production measured by DCF ﬂuorescence; B: glutathione (GSH) level; C: oxidized glutathione (GSSG) level; D: GSH/GSSG ratio; E: pAkt
(Ser473) level; F: pAkt (Thr308) level; G: pGSK3β level; and H: pPTEN level. Insets: Representative gel blots depicting proteins of interest (GAPDH as loading control). Mean ± SEM,
n = 5–6 mice per group, *p b 0.05 vs.WT group, #p b 0.05 vs.WT-LPS group.
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Fig. 5. Effect of Akt overexpression (AOE) on LPS-induced ER stress. WT and AOEmice received (4 mg/kg, i.p., 6 h) prior to assessment of ER stress. A: pERK level; B: pJNK level; C: pp38
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853M. Dong et al. / Biochimica et Biophysica Acta 1832 (2013) 848–863homogenates were centrifuged at 13,500 ×g (30 min) and supernatant
fractions were collected and were used to assay total GSH and GSSG by
the standard recycling method. Half of each sample was used for GSH.
Samples for GSSG determination were incubated at room temperature
with 2 μl 4-vinyl pyridine (4-vp) per 100 μl sample for 1 h after vigor-
ous vortexing. Incubation with 4-vp conjugates any GSH present in
the sample thus only GSSG is recycled to GSH without potential inter-
ference by GSH. The GSSG (as GSH × 2) was subtracted from the total
GSH to determine actual GSH level and GSH/GSSG level [27].
2.9. Western blot analysis
Expression of the stress signalingmolecules ERK, JNK and p38, the ER
stress proteins GRP78, Gadd153 and eIF2α, the autophagy markersBeclin-1, LC3B, Atg7 and p62 as well as the proinﬂammatory markers
TNFα, IL-1β and IL-6, the Akt signals Akt, PTEN and GSK3β, as well as
the apoptotic markers Bax, Bcl-2, caspase-3 and -9 were assessed. In
brief, left ventricular tissue was sonicated in a lysis buffer containing (in
mM): TRIS 10, NaCl 150, EDTA 5, 1%Triton X-100 and protease inhibitor
cocktail followed by centrifugation at 12,000 g for 10 min. Equal amount
(30 μg) protein was separated using 7–15% SDS-polyacrylamide gels in
minigel apparatus (Mini-PROTEAN II, Bio-Rad, Hercules, CA), and were
transferred to nitrocellulose membranes (0.2 μm pore size, Bio-Rad).
Membranes were blocked for 1 h in 5% nonfat milk before being
rinsed in TBS-T. The membranes were incubated overnight at 4 °C with
primary antibodies (1:1000) against protein of interest (Santa Cruz Bio-
technology, Santa Cruz, CA or Cell Signaling Technology, Beverly, MA).
After incubation with primary antibodies, blots were incubated with
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855M. Dong et al. / Biochimica et Biophysica Acta 1832 (2013) 848–863horseradish peroxidase-linked secondary antibodies (1:5000) for 60 min
at room temperature. Immunoreactive bands were detected using Super
Signal West Dura Extended Duration Substrate (Pierce, Milwaukee, WI).
The intensity of bands was measured with a scanning densitometer
(Model GS-800, Bio-Rad) coupled with a Bio-Rad personal computer
analysis software. GAPDH was used as the loading control [21,27].
GAPDH was chosen over β-actin as the loading control marker since the
later has been shown to be affected bymalnutrition state such as cachexia
[28].2.10. Statistical analysis
Data were mean ± SEM. Difference was assessed using one-way
analysis of variance (ANOVA) followed by a Tukey's post hoc test. A
p value b 0.05 was considered statistically signiﬁcant.3. Results
3.1. General biometric and echocardiographic properties of WT and AOE
mice
LPS treatment did not affect the body, liver, or kidney weights in ei-
ther WT or AOE mice. AOE transgene itself did not affect the body or
organweights. LPS signiﬁcantly increased LVESDwhile reduced fraction-
al shortening and ejection fraction (p b 0.05 vs. LPS-untreated groups),
the effect of which was ablated by Akt activation. Akt transgene itself
did not affect ESD, fractional shortening and ejection fraction (Table 1).
3.2. Langendorff-perfused heart function of WT and AOE mice
The Langendorff perfused heart assessment revealed that LPS
challenge signiﬁcantly decreased LVDP, the maximal rate of LV
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decline (−dP/dt) inWT group (p b 0.05 vs. LPS untreated hearts), the
effect of which was abrogated by Akt activation. Chronic Akt activa-
tion did not elicit any notable effects on Langendorff perfused heart
function (Fig. 1).
3.3. Mechanical and intracellular Ca2+ properties of cardiomyocytes
Mechanical properties revealed unchanged resting cell length
regardless of LPS exposure or Akt activation (p > 0.05). LPS chal-
lenge reduced peak shortening and maximal velocity of shorten-
ing/relengthening (±dL/dt), prolonged TR90 associated withcomparable TPS (p b 0.05 vs. LPS untreated groups), the effects of
which were ablated by Akt transgene. Akt transgene itself did not
exert any notable effect on cell mechanics (Fig. 2). To understand
the mechanism(s) behind Akt activation-offered cardiac protection,
Fura-2 ﬂuorescence was monitored to evaluate intracellular Ca2+
handling. Cardiomyocytes displayed signiﬁcantly reduced intracel-
lular Ca2+ release in response to electrical stimuli (ΔFFI) and
prolonged intracellular Ca2+ decay (single or bi-exponential curve
ﬁtting, p b 0.05 vs. LPS untreated groups) along with unchanged
resting intracellular Ca2+ (resting FFI) following LPS treatment, the
effect of which was reconciled by Akt activation. Akt transgene itself
did not alter intracellular Ca2+ homeostasis (Fig. 3).
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stress
To examine the potential mechanism behind Akt-elicited protec-
tion against LPS-induced cardiac mechanical anomalies, ROS was
evaluated using DCF ﬂuorescence in cardiomyocytes, and GSH/GSSG
assay in myocardial tissues fromWT and Akt transgenic mice. Results
shown in Fig. 4A–D indicate that ROS production was signiﬁcantly
enhanced whereas GSH levels and GSH/GSSG ratio was overtly re-
duced following LPS treatment (p b 0.05 vs. LPS untreated groups).
Consistent with its mechanical responses, Akt activation obliter-
ated LPS-induced increase in ROS production and drop in GSH
and GSH/GSSG ratio. Akt activation exerted little effects on ROS produc-
tion and oxidative stress (GSH levels and GSH/GSSG ratio).
3.5. Effects of Akt activation on LPS-induced ER stress response
As depicted in Fig. 5, Western blot analysis demonstrated a robust
increase in the ER stress protein markers including GRP78, Gadd153,
peIF2α, as well as phosphorylation of the stress signaling p38, ERK,
and JNK (p b 0.05 vs. LPS untreated groups), the effects were ablated
by Akt activation. Akt activation itself did not affect ER stress or stress
signaling activation.
3.6. Effects of Akt activation on LPS-induced changes on Akt signal pathways
Western blot analysis revealed signiﬁcantly increased phosphory-
lation of Akt (Ser473 and Thr308) and GSK3β in myocardium fromWTand AOE mouse hearts following LPS treatment (p b 0.05 vs. LPS
untreated groups). Akt activation exerted notable increase in the
phosphorylation of Akt (Ser473 and Thr308) without notable effect
on GSK3β phosphorylation. Examination of the Akt negative regular
PTEN phosphorylation revealed little change in WT or AOE myocardi-
um, regardless of LPS challenge (Fig. 4E–H).
3.7. Effects of Akt activation on LPS-induced changes on proinﬂammatory
cytokines
To detect the effect of inﬂammation on Akt-induced cardioprotection
against LPS, levels of the proinﬂammatory cytokines such as TNFα, IL-1β
and IL-6 were evaluated. As shown in Fig. 6A–D, LPS signiﬁcantly
upregulated expression of TNFα, IL-1β and IL-6 as well as phosphoryla-
tion of the NFКB inhibitory protein IκBα (p b 0.05 vs. LPS untreated
groups). Although Akt activation did not affect levels (or phosphoryla-
tion) of these proinﬂammatory cytokines, it mitigated LPS-induced
changes in these cytokines.
3.8. Effects of Akt activation on LPS-induced changes on apoptotic markers
To evaluate the possible role of apoptosis in Akt activation-offered
cardioprotection against LPS treatment, the apoptotic proteins Bax,
caspase-3, -9 and Bcl-2 were examined. As shown in Fig. 6E–H, LPS
challenge signiﬁcantly upregulated expression of Bax, caspase-3 and
-9, while reducing the level of Bcl-2 (p b 0.05 vs. LPS untreated
groups), the effects of which were ablated by Akt activation. Akt acti-
vation itself did not affect these apoptotic markers.
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To explore if autophagy contributes to Akt activation-offered
cardioprotection against LPS treatment, levels of autophagic markers
including Beclin-1, Atg7, Atg5 and LC3B were evaluated. ResultsFig. 11. Effect of SB216763 (10 μM) on the levels of apoptotic proteins Bax, caspase-3, -9 and
A: Bax levels; B: Bcl-2 levels; C: cleaved caspase-3 levels; D: cleaved caspase-9 levels. Ins
caspase-9 and GAPDH (loading control). Mean ± SEM, n = 5–8 isolations per group; *p
LPS-induced cardiac contractile dysfunction, intracellular Ca2+ mishandling, oxidative stre
Activation of Akt rescues against LPS-induced anomalies possibly through a mechanism in
result, Akt activation ameliorates LPS-induced oxidative stress, ER stress and apoptosis en rshown in Fig. 7 depicted that LPS signiﬁcantly increased levels of
Beclin-1, Atg7 and the LC3B II/I ratio while suppressing p62 accumu-
lation (p b 0.05 vs. LPS untreated groups), the effects of which were
unaffected by Akt activation (with the exception of p62). Akt activa-
tion itself did not alter levels of these autophagic markers.Bcl-2 in cardiomyocytes fromWT and AOE mice following LPS exposure (4 μg/ml, 2 h).
ets: Representative gel blots depicting levels of Bax, Bcl-2, cleaved caspase-3, cleaved
b 0.05 vs. WT group, #p b 0.05 vs. WT-LPS group. E: Schematic diagram depicting
ss, ER stress, apoptosis and inﬂammation in vivo (left panel) and in vitro (right panel).
volving alleviation of pro-inﬂammatory cytokines and stress signaling activation. As a
oute to cardioprotection.
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860 M. Dong et al. / Biochimica et Biophysica Acta 1832 (2013) 848–8633.10. Effect of Akt activation and GSK3β inhibition on LPS-induced changes
in mechanical and intracellular Ca2+ properties in cardiomyocytes in vitro
Our in vitro data revealed that LPS exposure signiﬁcantly
decreased peak shortening and maximal velocity of shortening/
relengthening (±dL/dt), prolonged TR90 without affecting TPS
(p b 0.05 vs. LPS untreated group), in a manner reminiscent of
in vivo LPS treatment. Although Akt activation and GSK3β inhibition
using SB216763 failed to exert notable effects themselves on cardio-
myocyte mechanics, they effectively ablated LPS-induced changes
in cardiomyocyte mechanical and intracellular Ca2+ properties. Neither
Akt activation nor SB216763 affected cardiomyocyte mechanics and
intracellular Ca2+ homeostasis (Figs. 8 & 9).
3.11. Effect of Akt activation and SB216763 on LPS-induced ER stress in
vitro
As shown in Fig. 10A–C, Western blot analysis revealed a robust
increase in ER stress manifested by GRP78, Gadd153 and peIF2α in
cardiomyocytes from WT mouse hearts (p b 0.05 vs. LPS untreated
group). Chronic Akt activation and SB216763 signiﬁcantly attenuated
LPS-induced changes in these ER stress markers without eliciting any
notable effect by themselves.
3.12. Effect of SB216763 on proinﬂammatory cytokines following LPS
treatment in vitro
As shown in Fig. 10E–H, LPS signiﬁcantly induced expression
of pIκBα, TNFα, IL-1β, and IL-6 in cardiomyocytes (p b 0.05 vs.
LPS untreated groups), the effect of which was attenuated or ab-
lated by chronic Akt activation or SB216763. Neither Akt activa-
tion nor SB216763 affected the levels of these proinﬂammatory
cytokines.
3.13. Effect of SB216763 on apoptotic proteins following LPS treatment in
vitro
As shown in Fig. 11A–D, LPS signiﬁcantly induced expression of Bax,
caspase-3 and -9, while it reduced Bcl-2 expression in cardiomyocytes
(p b 0.05 vs. LPS untreated group), the effects of which were ablated by
Akt overexpression or SB216763. Neither Akt activation nor SB216763
alone affected levels of these apoptotic proteins.
4. Discussion
The salient ﬁnding of our study showed that chronic Akt activa-
tion alleviates cardiac contractile and intracellular Ca2+ defect,
ROS accumulation, oxidative stress, ER stress and apoptosis as well
as downregulates proinﬂammatory cytokines following LPS challenge.
These ﬁndings implicated a protective effect of Akt against septic
shock, implicating the therapeutic potential of Akt in the management
of cardiac anomalies in sepsis. These ﬁndings are supportive to the no-
tion for a role of the Akt downstream signaling molecule GSK3β in
endotoxemia organ injury [15–20]. Previous reports have demonstrated
that chronic Akt activation,with time,may promote cardiac hypertrophy,
ﬁbrosis and pronounced cardiac injury in response to ischemia/perfusion
challenge [29–32]. Similar ﬁnding was noted by our group in old Akt
transgenic mice [33]. However, in this study, 8–12 week-old mice were
employed and the results failed to reveal overt changes in cardiac geom-
etry and contractile function, suggesting that endogenous overactivation
of Akt may not be innately harmful at a younger age.
Ample clinical and experimental evidence has consolidated
cardiac contractile anomalies in sepsis [21,26]. Echocardiographic
and cardiomyocyte mechanical observations from our present study
revealed enlarged left ventricular end systolic diameter, decreased
ejection fraction, fractional shortening, peak shortening, and maximalvelocity of shortening/relengthening, as well as prolonged relaxation
in associationwithminimal changes in LV diastolic diameter following
LPS challenge. This is substantiated by the Langendorff perfused heart
system where LPS decreased LVDP, maximum rate of LV pressure de-
velopment (+dP/dt) and decline (−dP/dt). These ﬁndings favor the
presence of mixed systolic and diastolic dysfunction in response to LPS
challenge. The inconsistent ﬁndings in the systolic versus diastolic pa-
rametersmay be due to difference in levels of assessment (in vivo echo-
cardiographic, ex vivo perfused heart and isolated cardiomyocytes).
Interestingly, our study revealed that Akt activation attenuated or miti-
gated LPS-induced myocardial dysfunction. Further observation
displayed reduced intracellular Ca2+ release in response to electrical
stimuli (ΔFFI) and prolonged intracellular Ca2+ decay with unchanged
resting intracellular Ca2+ (resting FFI) in cardiomyocytes from
LPS-challengedWTmice, the effect of whichwas reconciled by Akt acti-
vation. These ﬁndings depicted a role of intracellular Ca2+ handling in
LPS- andAkt activation-induced changes inmyocardial contractile func-
tion. Our examination of the signaling molecules related to Akt signal-
ing including PTEN and GSK3β revealed little role in the Akt negative
regulator PTEN in LPS- and Akt activation-induced myocardial
responsiveness. However, reduced phosphorylation of GSK3β was
noted following LPS treatment, the effect of which was reversed by
Akt overactivation. GSK3β is a highly conserved protein kinase ubiqui-
tously expressed in nearly all mammalian tissues [34,35]. GSK3β is in-
volved in a multitude of biological process such as cell cycle control,
cell differentiation, cell motility, adhesion and inﬂammation [36].
PI3K/Akt inactivates GSK3β (phosphorylation) to beneﬁt cell survival
and suppress inﬂammation [20,37]. As our data indicated, reduced inac-
tivation of GSK3βmay be involved in LPS-induced cardiac anomalies, in
line with a recent report where PI3K protects against sepsis through
GSK3β phosphorylation in a murine model of cardiac-speciﬁc
overexpression of PI3K p110α [38]. Accumulating evidence has re-
vealed proven beneﬁt of GSK3β inhibition in endotoxemia-associated
organ injury [15–20].
Our results indicated that chronic Akt activation alleviated ROS pro-
duction, oxidative and ER stress as depicted by ERK, p38, JNK, GRP78,
Gadd153, peIF2α, and GSH/GSSG ratio. Moreover, chronic Akt activation
inhibited proinﬂammatory and proapoptotic molecules such as TNFα,
IL-1β, IL-6, Bax, caspase-3, and caspase-9. These ﬁndings suggested a
beneﬁcial role of Akt in sepsis-induced cellular injuries including oxida-
tive damage, ER stress, inﬂammation and apoptosis. Meanwhile, our
data further indicated activated NF-κB following LPS challenge as
manifested by elevated IκBα phosphorylation, the effect of which was
nulliﬁed by Akt activation. These ﬁndings favor a role of cytokine and
inﬂammation in PI3K/Akt-elicited cytoprotection, consistent with the
notion for a role of PI3K/Akt in the regulation of host immune homeosta-
sis and sepsis [39–41]. PI3K/Akt may neutralize the deleterious action of
NF-κB to alleviate organ damage in sepsis [42,43]. Akt is capable of atten-
uating inﬂammation through inactivating NF-κB by way of suppression
of mitogen-activated kinase (p38) and c-Jun N-terminal kinase
(JNK) [44,45]. NF-κB inhibitor was found to signiﬁcantly attenuate
TNFα-induced cytotoxicity along with preserved PI3K/Akt signaling
[46]. Interleukin-1 (IL-1) was initially described as the ﬁrst “endogenous
pyrogen” with an essential role in myocardial dysfunction and infarct
healing [47]. The pro-inﬂammatory cytokines such as TNFα, IL-1β and
IL-6 have been shown to trigger heart anomalies through induction of
apoptosis, impairment of bone marrow function, and interruption of
endothelial cell function [48]. As shown in our study, changes in
proinﬂammatory cytokines (TNFα, IL-1β and IL-6) and stress signaling
molecules coincided with phosphorylation of IκBα in response to LPS
challenge andAkt activation. These data support a role of NF-κB signaling
in Akt activation-induced protection against LPS-induced cell stress and
inﬂammation in the heart.
ER stress refers to unfolded protein response (UPR), or an imbal-
ance between delivery of unfolded proteins to the ER and the ER
capacity for cellular folding [49]. Three ER integral membrane
861M. Dong et al. / Biochimica et Biophysica Acta 1832 (2013) 848–863proteins namely PERK (RNA-activated protein kinase-like ER kinase),
IRE (inositol-requiring kinase) and ATF6 (activating transcription fac-
tor) comprise the main pathways for ER stress [50]. ER stress plays a
rather pivotal role in diabetes mellitus, neurodegenerative diseases,
obesity, trauma and ischemic heart diseases [51–54]. It is believed
that sepsis perturbs the ER, leading to a situation of ER stress [55].
In our in vivo study, ER stress markers including GRP78, Gadd153
and peIF2α were markedly elevated in response to LPS challenge,
the effects of which were attenuated or obliterated by chronic Akt ac-
tivation. Similar results were found from in vitro study where
SB216763 (an inhibitor of GSK3β) inhibits LPS-induced ER stress
and contractile dysfunction in cardiomyocytes, consistent with our
previous report that ER stress contributes to cardiac dysfunction
[14]. Although ROS may be necessary for normal cellular function
and survival, oxidative stress develops when the balance between
ROS production and clearance is interrupted [56]. LPS induces super-
oxide production to promote oxidative stress [57]. Findings from our
study revealed that LPS prompted accumulation of ROS and oxidative
stress (reduced GSH/GSSG ratio) in conjunction with impaired cardi-
ac contraction and intracellular Ca2+ handling. Our result revealed
that Akt may exert its beneﬁcial role in sepsis through alleviating
LPS-induced ROS production and oxidative stress.
Apoptosis plays an important role in awide variety of cardiovascular
diseases including ischemia/reperfusion injury, atherosclerosis, alco-
holic cardiomyopathy, diabetic cardiomyopathy and sepsis-associated
cardiac dysfunction [58–60]. Our results demonstrated that Akt activa-
tion ablated sepsis-elicited activation of stress signaling (ERK, JNK and
p38) and apoptosis (Bax, Bcl-2, caspase-3 and -9), in line with the
changes in ROS accumulation and the proinﬂammatory cytokines. This
is consistent with the notion that endotoxin is capable of inducing
proapoptotic markers such as Bax and caspase-3 in the heart to contrib-
ute to heart defect [61,62]. Activation ofMAPK stress signaling has been
widely documented in septic heart contributing to cell death and myo-
cardial dysfunction [21,26]. In our study, we also found that LPS
upregulated the levels of Bax, caspase-3 and -9 while downregulating
the anti-apoptotic protein Bcl-2. Although Akt activation did not exert
any effect on these apoptotic proteins, it ablated LPS-induced changes
in these apoptosis markers. In vitro evidence further revealed that
SB216763 mimicked the effect of Akt activation upon LPS challenge.
Data from our study revealed increased proinﬂammatory factors such
as TNFα, IL-1β and IL-6 along with ROS accumulation and ER stress fol-
lowing LPS challenge. Chronic Akt activation alleviated ROS production,
ER stress, and apoptosis in response to LPS challenge. Adequate ER
reaction and ROS production are the biologically protective responses
although excessive ER stress and ROS production are deemed deleteri-
ous. Excessive ER stress and oxidative stress may induce apoptosis
[63]. Many studies have demonstrated that PI3K/Akt may suppress ap-
optosis in macrophages, lymphocytes and neutrophils to protect the
host against sepsis [64,65]. In particular, cardiac-speciﬁc PI3K p110α
may suppress apoptosis in sepsis [38]. These ﬁndings are in all favor
of a pivotal role of Akt in attenuating LPS-induced myocardial damage
through inhibition of apoptosis.
Autophagy is a conserved cellular mechanism through which
mammalian cells degrade and recycle damaged macromolecules and
organelles [66,67]. A role of autophagy has been reported in an
array of cardiovascular diseases including obesity, sepsis, aging, alco-
holism and ischemic injury [68–74]. Autophagy usually starts with an
“induction phase” which is initiated by Beclin-1 as an internal stimu-
lus followed by a second “formation phase” involving Atg proteins
such as Atg7 and autophagosome membrane speciﬁc protein light
chain 3 (LC3) or Atg8 [75]. Sequestosome-1 (SQSTM, also known as
p62) is an adaptor for autophagosome formation. The higher expres-
sion of p62 usually means hindering of fusion of autophagosome and
lysosome [76,77]. Data from our study suggest that LPS facilitates
levels of autophagy as depicted by higher levels of Beclin-1, Atg7,
LC3B, and LC3B II-to LC3B I ratio, as well as decreased p62 in WTmice. Akt activation failed to attenuate or reverse LPS-induced re-
sponses in autophagy signaling molecules, suggesting a lesser role
of autophagy in Akt-induced cardioprotection against sepsis.
In conclusion, data from our study revealed that chronic Akt activa-
tion rescues against LPS-induced cardiac contractile and intracellular
Ca2+ anomalies as well as cell death through an Akt/GSK3β-dependent
mechanism involving interplay between activation of proinﬂammatory
cytokines and stress signaling (Fig. 11E). Akt activation alleviates stress
signaling activation, oxidative stress, ER stress, apoptosis and inﬂamma-
tion in sepsis. These results may implicate the possible therapeutic
potential of Akt cascade in the management of cardiac dysfunction
in sepsis. Nonetheless, although LPS infusion/injection has been
widely employed for sepsis research to mimic many of the initial
clinical features of sepsis including increases in proinﬂammatory cy-
tokines such as TNF-α and interleukin-1, it suffers from limitations
such as lack of bacteremia compared with sepsis resulted from intes-
tinal leakage (e.g., cecal ligation and puncture or colon ascendens
stent peritonitis) [78]. To this end, precaution should be taken to
apply knowledge obtained from LPS endotoxemia animal model to
human sepsis.
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